Venture Capital
Central, Hong Kong Island
Ally Bridge Group announced key promotions and a new appointment. The group has also made several outgoing investments, including $150 million in INSIGHTEC, $126 million in Transcarent, $259 million in Alumis, $125 million in Mainstay Medical, and $132.5 million in Endeavor BioMedicines. We invest across the global healthcare industry and investments are made across the capital structure in one of two complementary strategies: private equity and public equity. Ally Bridge does not disclose any nonpublic personally identifiable information about its Site users to any nonaffiliated third party, except as set forth below.
10524sbs
